Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy

Annals of Neurology

Volumn 54, Issue 3, 2003, Pages 379-382

  Lee, Jin Moo ^a   Yin, Ke Jie ^a   Hsin, Idar ^a   Chen, Shawei ^a   Fryer, John D ^a   Holtzman, David M ^a   Hsu, Chung Y ^b   Xu, Jian ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; GELATINASE B; PROTEIN SUBUNIT;

AGE; AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME DEGRADATION; ENZYME RELEASE; EXTRACELLULAR MATRIX; IMMUNOREACTIVITY; MICROVASCULATURE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE; TRANSGENIC MOUSE; VASCULAR AMYLOIDOSIS; WILD TYPE;

AGING; AMYLOID BETA-PROTEIN; ANIMALS; BLOTTING, WESTERN; CAPILLARIES; CELLS, CULTURED; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL CORTEX; CEREBRAL HEMORRHAGE; CEREBROVASCULAR CIRCULATION; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; MICE; MICE, TRANSGENIC; MODELS, ANIMAL;

EID: 0041835847     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10671     Document Type: Article

References (20)

1. Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke 1987;18:311-324.
2. Coria F, Rubio I. Cerebral amyloid angiopathies. Neuropathol Appl Neurobiol 1996;22:216-227.
3. Greenberg SM. Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology 1998;51:690-694.
4. Sturchler-Pierrat C, Abramowski D, Duke M, et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 1997;94:13287-13292.
5. Hsiao K, Chapman P, Nilsen S, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996;274:99-102.
6. Calhoun ME, Burgermeister P, Phinney AL, et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA 1999;96:14088-14093.
7. Holtzman DM, Fagan AM, Mackey B, et al. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann Neurol 2000;47:739-747.
8. Winkler DT, Biedermann L, Tolnay M, et al. Thrombolysis induces cerebral hemorrhage in a mouse model of cerebral amyloid angiopathy. Ann Neurol 2002;51:790-793.
9. Pfeifer M, Boncristiano S, Bondolfi L, et al. Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science 2002; 298:1379.
10. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002;90:251-262.
11. Pyo R, Lee JK, Shipley JM, et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000;105:1641-1649.
12. Lapchak PA, Chapman DF, Zivin JA. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke 2000;31:3034-3040.
13. Sumii T, Lo EH. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 2002;33:831-836.
14. Yin KJ, Lee JM, Chen SD, et al. Amyloid-beta induces Smac release via AP-1/Bim activation in cerebral endothelial cells. J Neurosci 2002;22:9764-9770.
15. Zhang JW, Gottschall PE. Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification. J Neurosci Methods 1997;76:15-20.
16. Roher AE, Lowenson JD, Clarke S, et al. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem 1993;268:3072-3083.
17. Parks WC, Meecham RP. Matrix metalloproteinases. San Diego: Academic Press, 1998.
18. Deb S, Gottschall PE. Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides. J Neurochem 1996;66:1641-1647.
19. Romanic AM, White RF, Arleth AJ, et al. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998;29:1020-1030.
20. Gasche Y, Fujimura M, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J Cereb Blood Flow Metab 1999;19:1020-1028